Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus [NA]

View source ↗

Summary

This Clinical Trials entry reports on BRL-301 universal CAR-T cells being studied for refractory systemic lupus erythematosus, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BRL-301 (BRL-301 CAR-T cells)

Snippet

Sponsor: Bioray Laboratories | Conditions: Systemic Lupus Erythematosus (SLE) | NA | Status: RECRUITING